Chrozophora tinctoria (L.) A. Juss is an herb belongs to the family Euphorbiaceae having various medicinal and therapeutic importance. The current article covers an emphasis on the key aspects of plant Chrozophora tinctoria with regards to their phytosomal gel uses in wound healing potential.

Keywords : Chrozophora tinctoria, Euphorbiaceae, Wound, Phtosomal.

[1]. Abdallah, H. M., Almowallad, F. M., Esmat, A., Shehata, I. A., & Abdel-Sattar, E. A. (2015). Anti-inflammatory activity of flavonoids from Chrozophora tinctoria. Phytochemistry Letters, 13, 74-80.
[2]. Abdel-Naim, A. B., Alghamdi, A. A., Algandaby, M. M., Al-Abbasi, F. A., Al-Abd, A. M., Eid, B. G., ... & El-Halawany, A. M. (2018). Rutin isolated from Chrozophora tinctoria enhances bone cell proliferation and ossification markers. Oxidative Medicine and Cellular Longevity, 2018(1), 5106469.
[3]. Al-Snafi, A. E. (2014). Chemical constituents and pharmacological activities of Arachishypogaea. –A review. International Journal for Pharmaceutical Research Scholars, 3(1-1), 615-623.
[4]. Dastagir, G., &Hussain, F. (2013). Phytotoxic and insecticidal activity of plants of family Zygophyllaceae and Euphorbiaceae. Sarhad J. Agric, 29(1), 83-91.
[5]. Iqbal, A., Sher, A. A., Muhammad, N., Badshah, S. L., Emwas, A. H., &Jaremko, M. (2022). Extraction and fractionation of prokinetic phytochemicals from Chrozophora tinctoria and their bioactivities. Molecules, 27(13), 4321.

Introduction: In recent decades, the sale of medicines outside the official pharmacy circuit has become widespread in developing countries. Niger and other developing countries, which are heavily dependent on imports, need to set up and maintain an effective product testing program. The aim of this study is to compare the quality of analgesics (paracetamol, aspirin, ibuprofen, diclofenac sodium and tramadol) with reference products of known quality......

.

Keywords : quality control; illicit market; pharmacy; analgesic; Niger

[1]. Maritoux J. Marché pharmaceutique parallèle, ventes illicites et santé publique. Journal de ReMeD, 1999, [en ligne] disponible sur http://www.remed.org/marche_illicite.pdf (consulté le 06/01/2021).
[2]. Ordonnance N°97-002 du 10 janvier 1997 portant Législation Pharmaceutique. Ministère de la santé publique au Niger. 1997, 33p.
[3]. Diallo M. Contribution à l'évaluation du marché illicite du Médicament au Niger à partir des Statistiques douanières d'importation des médicaments, réactifs de laboratoires et consommables médicaux de 1999 à 2003, [en ligne] disponible sur www.remed.org/marche_illicite_niger.pdf.
[4]. Konaté A. Contribution au contrôle de qualité des médicaments au LNS : Analyse rétrospective de 1997 à 2011. Thèse de Pharma. Faculté de médecine de pharmacie et d'odonto-stomatologie. Bamako-Mali, 2013, 94p.
[5]. Abdou Idrissa H. Les médicaments de la rue à Niamey : modalités de vente et contrôle de qualité de quelques médicaments anti-infectieux. Thèse de Pharma. Faculté de médecine de pharmacie et d'odonto-stomatologie. Bamako-Mali, 2005. 140p.

Onychomycosis is one of the common nail diseases worldwide and it is a fungal infection that chiefly involves the nails on fingers and toes. Secondary to dermatophytes but caused by yeasts and non-dermatophyte moulds as well. Though not lethal, they erode the quality of life of the affected patients due to pain and discomfort, unsightly nails, and the consequent social repercussions. Since I was comparing the prevalence in two populations, I had to get the estimates for the prevalence in the two groups separately from the literature: The prevalence rises with age and depends on risk factors such as immunosuppression, diabetes and working in wet conditions for a long time.......

[1]. Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol. 1995;133(5):699–703.
[2]. Roseeuw D. Achilles foot screening project: preliminary results of patients screened by dermatologists. J Eur Acad Dermatology Venereol. 1999;12(s1).
[3]. Scher RK, Rich P, Pariser D, Elewski B. The epidemiology, etiology, and pathophysiology of onychomycosis. Semin Cutan Med Surg. 2013;32:S2–4.
[4]. Nouripour-Sisakht S, Mirhendi H, Shidfar MR, Ahmadi B, Rezaei-Matehkolaei A, Geramishoar M, et al. Aspergillus species as emerging causative agents of onychomycosis. J Mycol Med. 2015;25(2):101–7.
[5]. Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment. Vol. 66, Journal of the American Academy of Dermatology. 2012. p. 494–502.